1. Home
  2. NVAX vs RNST Comparison

NVAX vs RNST Comparison

Compare NVAX & RNST Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NVAX
  • RNST
  • Stock Information
  • Founded
  • NVAX 1987
  • RNST 1904
  • Country
  • NVAX United States
  • RNST United States
  • Employees
  • NVAX N/A
  • RNST N/A
  • Industry
  • NVAX Biotechnology: Biological Products (No Diagnostic Substances)
  • RNST Major Banks
  • Sector
  • NVAX Health Care
  • RNST Finance
  • Exchange
  • NVAX Nasdaq
  • RNST Nasdaq
  • Market Cap
  • NVAX 1.3B
  • RNST 3.3B
  • IPO Year
  • NVAX 1995
  • RNST N/A
  • Fundamental
  • Price
  • NVAX $6.84
  • RNST $38.52
  • Analyst Decision
  • NVAX Buy
  • RNST Buy
  • Analyst Count
  • NVAX 5
  • RNST 6
  • Target Price
  • NVAX $16.60
  • RNST $42.20
  • AVG Volume (30 Days)
  • NVAX 4.9M
  • RNST 541.9K
  • Earning Date
  • NVAX 08-07-2025
  • RNST 07-22-2025
  • Dividend Yield
  • NVAX N/A
  • RNST 2.27%
  • EPS Growth
  • NVAX N/A
  • RNST 31.26
  • EPS
  • NVAX 2.97
  • RNST 3.20
  • Revenue
  • NVAX $1,254,962,000.00
  • RNST $710,265,000.00
  • Revenue This Year
  • NVAX $56.85
  • RNST $40.84
  • Revenue Next Year
  • NVAX N/A
  • RNST $13.45
  • P/E Ratio
  • NVAX $2.30
  • RNST $12.09
  • Revenue Growth
  • NVAX 25.92
  • RNST 15.97
  • 52 Week Low
  • NVAX $5.01
  • RNST $26.97
  • 52 Week High
  • NVAX $17.81
  • RNST $39.63
  • Technical
  • Relative Strength Index (RSI)
  • NVAX 51.12
  • RNST 66.56
  • Support Level
  • NVAX $6.54
  • RNST $37.38
  • Resistance Level
  • NVAX $7.20
  • RNST $38.91
  • Average True Range (ATR)
  • NVAX 0.28
  • RNST 0.79
  • MACD
  • NVAX 0.06
  • RNST 0.21
  • Stochastic Oscillator
  • NVAX 66.36
  • RNST 91.18

About NVAX Novavax Inc.

Novavax Inc is a biotechnology company that develops vaccines. The company works in the clinical stage of development with a focus on delivering novel products that prevent a broad range of diseases. It works together with its wholly owned Swedish subsidiary to produce vaccine candidates to respond to both known and emerging disease threats. The company believes its vaccine technology has the potential to be applied broadly to a wide variety of human infectious diseases. The company manages its business as one operating segment, the development and commercialization of vaccines. The company generates maximum revenue from the United States.

About RNST Renasant Corporation

Renasant Corp operates as a holding company for Renasant Bank, a Mississippi banking corporation, and its subsidiary, Renasant Insurance, Inc. It has three reportable segments: Community banks, Insurance, and Wealth management. With its Community banks segment, the company provides a range of financial services to individuals and small businesses. Its Insurance segment is an insurance agency providing commercial and personal insurance through third-party carriers. The Wealth management segment provides a range of services, including money management and retirement planning. The majority of the company's revenue is driven by lending activities in its community banks segment.

Share on Social Networks: